Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Male or Female”

2,103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,103 results

Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Early research (Phase 1)Study completedNCT00754143
What this trial is testing

Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy

Who this might be right for
Diabetes MellitusDiabetic Nephropathy
Kyntra Bio 38
Not applicableLooking for participantsNCT04111692
What this trial is testing

A Prospective Observational Study of Foam Sclerotherapy .

Who this might be right for
Autosomal Dominant Polycystic KidneyRenal CystAutosomal Dominant Polycystic Liver Disease+1 more
Mayo Clinic 100
Early research (Phase 1)Looking for participantsNCT06479811
What this trial is testing

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Who this might be right for
Head and Neck TumorsKidney CancersSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI) 120
Large-scale testing (Phase 3)Study completedNCT02231749
What this trial is testing

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Bristol-Myers Squibb 1,390
Not applicableStudy completedNCT06733194
What this trial is testing

Complications of Bladder Augmentation in Children

Who this might be right for
Neurogenic Bladder DisorderSpina BifidaComplications of Surgical Procedures or Medical Care+2 more
University Hospital, Clermont-Ferrand 87
Early research (Phase 1)Active Not RecruitingNCT05614102
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 284
Not applicableUnknownNCT02592252
What this trial is testing

Impact of Microfinance and Participatory Gender Training for Women in Reducing Intimate Partner Violence

Who this might be right for
Maltreatment by Spouse or Partner
London School of Hygiene and Tropical Medicine 2,640
Not applicableStudy completedNCT03664258
What this trial is testing

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)

Who this might be right for
Non-muscle-invasive Bladder Cancer
Cepheid 852
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012371
What this trial is testing

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
M.D. Anderson Cancer Center 90
Not applicableUnknownNCT00912834
What this trial is testing

Study of Prevalence of Proteinuria, Urinary Tract Infection or Hematuria in Athletes

Who this might be right for
Proteinuria
Far Eastern Memorial Hospital 300
Not applicableStudy completedNCT01538433
What this trial is testing

A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 603
Early research (Phase 1)Ended earlyNCT05280717
What this trial is testing

Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)

Who this might be right for
Covid19
Vir Biotechnology, Inc. 316
Testing effectiveness (Phase 2)Study completedNCT00005817
What this trial is testing

Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IIIB Breast Cancer+1 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)UnknownNCT03961698
What this trial is testing

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Who this might be right for
Breast CancerRenal Cell Carcinoma
Infinity Pharmaceuticals, Inc. 91
Post-approval studies (Phase 4)UnknownNCT00719316
What this trial is testing

Aliskiren and Muscle Sympathetic Nerve Activity

Who this might be right for
Chronic Kidney DiseaseHypertensionMuscle Sympathetic Nerve Activity
UMC Utrecht 30
Large-scale testing (Phase 3)Study completedNCT04051710
What this trial is testing

Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH

Who this might be right for
Bronchial Asthma
Aurobindo Pharma Ltd 1,550
Early research (Phase 1)Study completedNCT01129388
What this trial is testing

Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects

Who this might be right for
Healthy
Sanofi 72
Testing effectiveness (Phase 2)Study completedNCT00515697
What this trial is testing

Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Eli Lilly and Company 39
Large-scale testing (Phase 3)Active Not RecruitingNCT05043090
What this trial is testing

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 148
Load More Results